ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 716,61
1,32%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Phio Pharmaceuticals Corporation (PHIO)

  7. Phio Pharmaceuticals Corporation (PHIO) Actualités

PHIO Phio Pharmaceuticals Corporation

0,88
0,1043 (13,45%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Phio Pharmaceuticals Corporation PHIO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,1043 13,45% 0,88 01:59:58
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,81 0,7762 0,8299 0,8197 0,7757
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
22/4/202419:10GLOBEIntratumoral Injection of Phio’s PH-762 significantly..
16/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentations at the..
11/4/202413:30GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
03/4/202413:30GLOBENational Spotlight Features Phio’s Innovative RNAi..
02/4/202413:30GLOBEPhio Pharmaceuticals Reports 2023 Year End Financial Results..
21/3/202412:30GLOBEPhio Pharmaceuticals Presenting Data Showing INTASYL May..
13/3/202419:00GLOBEPhio Pharmaceuticals Announces Addition of Clinical Trial..
06/3/202416:30GLOBEPhio Pharmaceuticals Announces Patent Granted by USPTO,..
06/3/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202416:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202414:00GLOBEPhio Pharmaceuticals Announces Data Showing INTASYL May..
26/1/202423:00EDGAR2Form 8-K - Current report
28/12/202315:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
19/12/202322:52EDGAR2Form S-1 - General form for registration of securities under..
08/12/202323:00EDGAR2Form 8-K - Current report
07/12/202314:00GLOBEPhio Pharmaceuticals Announces Exercise of Warrants for $2.8..
09/11/202322:40EDGAR2Form 8-K - Current report
09/11/202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:30GLOBEPhio Pharmaceuticals Reports Third Quarter 2023 Financial..
09/11/202313:30GLOBEPhio Pharmaceuticals Announces First US Patient Enrolled in..
03/11/202317:00GLOBEPhio Pharmaceuticals Presents New Data Showing INTASYL..
12/10/202317:00GLOBEPhio Pharmaceuticals Announces Upcoming Presentation at the..
11/10/202313:30GLOBEPhio Pharmaceuticals Presents New Data for Targeting of BRD4..
06/9/202313:30GLOBEPhio CEO to Speak at Wainwright Conference in New York in..
21/8/202313:30GLOBEPhio Pharmaceuticals Announces Dosing of First Patient in..
21/8/202313:30EDGAR2Form 8-K - Current report
10/8/202322:40EDGAR2Form 8-K - Current report
10/8/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:30GLOBEPhio Pharmaceuticals Reports Second Quarter 2023 Financial..
26/7/202322:30EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
PHIO
Phio Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés